Hemodynamic Instability and Resuscitation

Published on 13/02/2015 by admin

Filed under Cardiothoracic Surgery

Last modified 13/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3673 times

Chapter 20 Hemodynamic Instability and Resuscitation

Hemodynamic instability refers to abnormalities of heart rate, blood pressure, filling pressures, or cardiac output that if uncorrected result in organ dysfunction. Hemodynamic instability is common in the intensive care unit (ICU) and encompasses a range of clinical states, from cardiac arrest to subtle tissue hypoperfusion. When hemodynamic instability is obvious and severe, timely intervention may be lifesaving. Equally important is the early recognition and treatment of slowly evolving or subclinical tissue hypoperfusion which, untreated, may progress to organ failure.

This chapter is divided into three sections: (1) postoperative hypertension; (2) hypotension and low cardiac output; (3) cardiac arrest and near cardiac arrest. Relevant physiology and pharmacology are discussed in Chapters 1 and Chapter 3, respectively; echocardiography is reviewed in Chapter 7; and hemodynamic monitoring is discussed in Chapter 8.


Hypertension occurs because of increased systemic vascular resistance, increased cardiac output, or both (see Eq. 1-5). With increased systemic resistance, diastolic, systolic, and mean arterial pressures (MAP) are all increased. With increased stroke volume, diastolic pressure is usually normal or low, and pulse pressure is high. Postoperative hypertension has a number of causes (Table 20-1), but in most cases the primary problem is increased systemic vascular resistance. Surgical stress, hypothermia, patient anxiety, and inadequate analgesia lead to activation of the sympathetic nervous and renin-angiotensin-aldosterone systems. Essential hypertension is common and routine antihypertensive medications may have been withheld during the perioperative period.

Table 20-1 Etiology of Hypertension Following Cardiac Surgery

Common Causes of Hypertension Following Cardiac Surgery
Anxiety (including paralysis combined with inadequate sedation)
Withdrawal of usual oral antihypertensive treatment (particularly β blockers)
Inappropriate vasopressor therapy
Patient-ventilator dysynchrony
Poorly controlled essential hypertension
Uncommon Causes of Hypertension Associated With Cardiac Surgery
Myocardial ischemia or infarction
Acute left ventricular failure
Drug treatment (corticosteroids, cyclosporine)
Coarctation of the aorta
Aortic dissection
Intracranial catastrophe
Uncommon Causes of Hypertension not Associated With Cardiac Surgery
Renal disease (including renal artery stenosis, end-stage renal disease, glomerulonephritis, etc.)
Endocrine dysfunction (including primary hyperaldosteronism, Cushing syndrome, pheochromocytoma, renin-producing tumor)
Toxemia of pregnancy

Elevated systemic vascular resistance results in increased left ventricular afterload, which can lead to reduced stroke volume, especially in patients with impaired left ventricular function. Thus, hypertension may be associated with low cardiac output and tissue hypoperfusion. Hypertension can precipitate myocardial ischemia, arrhythmias, and pulmonary edema. It can exacerbate or precipitate mediastinal bleeding and can occasionally cause dehiscence of arterial suture lines, with potentially catastrophic results. Profound hypertension (diastolic pressure >140 to 150 mmHg) can cause cerebral edema or precipitate an intracerebral bleed, but such events are rare; hypertension is more likely to result from, rather than cause, raised intracranial pressure.

The definition of hypertension is arbitrary and must take into account a patient’s individual circumstances. For instance, in a postoperative patient who is bleeding, a MAP above 80 to 90 mmHg probably warrants pharmacologic treatment. By contrast, a patient who has essential hypertension several days after surgery and has evolving renal dysfunction may benefit from a MAP above 90 mmHg. A sustained MAP above 120 to 130 mmHg always warrants intervention.

Before antihypertensive drugs are given, the common causes of postoperative hypertension (see Table 20-1) should be considered and corrected. Clinicians must also assess the patient’s intravascular volume status and cardiac output (see subsequent discussion).

For intravenous antihypertensive therapy, vasodilators such as nitroglycerin, nicardipine, and nitroprusside are an attractive first choice because in patients with elevated systemic vascular resistance, they maintain or augment cardiac output. However, nitroglycerin may be ineffective in treating severe hypertension, and nitroprusside can cause marked hypotension, reflex tachycardia, and hypoxemia. Nesiritide may be considered when circulating volume is increased and filling pressures are high. If cardiac output is low, an inodilating drug such as milrinone is a good choice. Fluid loading may have to accompany vasodilating and inodilating drugs.

Intravenous metoprolol or diltiazem are good choices when hypertension is accompanied by tachycardia, but they must be used cautiously in the presence of impaired cardiac function. Labetalol, a combined α and β blocker, may be preferable to a pure β blocker in this circumstance.

Once a patient is able to take oral medications, a dihydropyridine calcium channel blocker (e.g., amlodipine or felodipine) or an angiotensin-converting enzyme (ACE) inhibitor (e.g., cilazapril or quinapril) may be substituted for intravenous vasodilators. Oral formulations of metoprolol or diltiazem may be substituted for intravenous formulations.

For resistant hypertension, combining a vasodilator and a β blocker is helpful. When hypertension is associated with central nervous system agitation or opioid withdrawal, clonidine or dexmedetomidine may be considered.


Recognizing and Treating Hemodynamic Instability

Severe hemodynamic instability is usually obvious, but identifying subtle derangements in cardiovascular function can be difficult.


Sustained hypotension below the lower limit of blood flow autoregulation leads to organ dysfunction. However, autoregulatory limits vary from patient to patient and organ to organ and are altered by disease. The autoregulatory range is set to a higher level in chronic hypertension but may disappear entirely with critical illness, in which case organ blood flow becomes pressure dependent. However, if MAP is maintained at the expense of cardiac output, organ hypoperfusion may occur despite adequate blood pressure.

There are limited data concerning what constitutes an ideal blood pressure in critically ill patients. In one study of patients with septic shock, increasing MAP from 65 to 85 mmHg with norepinephrine did not improve markers of tissue perfusion or renal function.1 In the absence of similar studies in cardiac surgical patients, a target MAP of more than 65 mmHg is a reasonable goal for most patients. Suggested blood pressure targets in different groups of cardiac surgery patients are listed in Table 20-2.

Table 20-2 Blood Pressure Targets in the First 48 Hours Following Cardiac Surgery

Normal (MAP >65 mmHg)
Default blood pressure goal
High (MAP >75-85 mmHg)
Age >75 years
Multiple arterial grafts
Preoperative or evolving renal impairment
Poorly controlled hypertension
History of ischemic stroke
New neurologic deficit postoperatively
Significant uncorrected carotid stenoses
Low (MAP >55-60 mmHg)
Age <50 years with no history of hypertension
High bleeding risk
Low blood pressure preoperatively with normal renal function
Valve surgery for chronically regurgitant valve lesions

MAP, mean arterial pressure.

Low Cardiac Output and Tissue Hypoperfusion

Unlike blood pressure, cardiac output is not routinely measured in all patients, and clinicians often rely on clinical and biochemical markers of tissue hypoperfusion (Table 20-3). Unfortunately, clinical assessment of cardiac output is unreliable in the first few hours after cardiac surgery.2 Cool peripheries are normal findings. Polyuria is common, even with evolving renal dysfunction. Tachycardia may be absent due to the inhibitory effects of cardiopulmonary bypass (CPB) and surgery on the cardiac conducting system. Lactic acidosis is suggestive of tissue hypoperfusion, but other causes (e.g., β2-agonist drugs; see Table 31-3) may be responsible. Not uncommonly, low cardiac output occurs in the absence of lactic acidosis. A useful screening tool for low cardiac output is the oxygen saturation of blood drawn from the proximal port of a central venous catheter (i.e., from the superior vena cava; SSVCO2), which provides a close approximation of a true mixed venous oxygen saturation SVO2.3 Values above 65% are reassuring; values below 55% warrant further investigation. Other findings that demand further investigations include escalating inotropic support, a central venous pressure (CVP) above 15 mmHg, and unexplained metabolic acidosis (lactate >5 mmol/l, base deficit >6).

Table 20-3 Clinical and Biochemical Signs Consistent with Inadequate Cardiac Output

Cool, clammy peripheries
Central hyperthermia
Oliguria with concentrated urine
Sinus tachycardia and atrial fibrillation
Narrow pulse pressure
Metabolic acidosis
Elevated lactate
Low SVO2 or SSVCO2

SSVCO2, superior vena cava oxygen saturation; SVO2, mixed venous oxygen saturation.

If low cardiac output is suspected—and the cause is not readily apparent on the basis of routine clinical assessment—cardiac output should be measured. Numerous devices may be used (see Chapter 8), but in cardiac surgery units, the pulmonary artery catheter (PAC) is the device most commonly employed. A PAC also allows measurement of pulmonary arterial pressure, pulmonary artery wedge pressure (PAWP), and SVO2. As with blood pressure, the normal value for cardiac output is ill defined. By convention, a lower limit of 2.2 l/min/m2 is widely used; however, many “well” cardiac surgery patients have values below this figure.2 Also, the appropriate cardiac output depends on the patient’s metabolic state. Thus, in a patient with a marked systemic inflammatory response to CPB, a cardiac output of 4 l/min/m2 may be appropriate, whereas in a sedated, mildly hypothermic patient, a value of 2 l/min/m2 may be satisfactory. As a simple guide, if filling pressures are normal (PAWP <15 mmHg, CVP <12 mmHg), and venous oxygen saturation is satisfactory (>65%), a cardiac output as low as 1.8 l/min/m2 is probably acceptable.

Diagnosis and Treatment

Causes of hemodynamic instability in the early postoperative period are listed in Table 20-4. A stepwise approach to the diagnosis and initial treatment of hemodynamic instability is provided in Table 20-5. Important diagnostic clues can be obtained from the patient’s history and intraoperative course. The operation notes, angiograms, and echocardiograms should be reviewed. Examination should focus on the cardiovascular system, in particular the presence of any new murmurs. Specific diagnoses may be suggested on the basis of the electrocardiogram (ECG), CVP, and arterial pressure waveforms (see Chapter 8). If the ECG trace is abnormal, 12-lead and atrial ECGs should be obtained. Respiratory problems can cause hemodynamic instability, and a careful respiratory system examination, including checking the ventilator circuit and settings, should be performed. Chest drain bottles should be inspected for blood loss and bubbling. Important trends may be identified on the 24-hour ICU chart. Further blood tests, such as arterial blood gases, complete blood count, coagulation status, and troponin may be indicated, depending on the circumstances. Chest radiographs should be reviewed.

Table 20-4 Causes of Hemodynamic Instability in the Early Period Following Cardiac Surgery

Common Uncommon
Patient-ventilator dysynchrony Severe mitral regurgitation
Hypovolemia Other valvular pathology
Low systemic vascular resistance Dynamic LVOT obstruction
Left ventricular systolic dysfunction Dynamic lung hyperinflation
Left ventricular diastolic dysfunction Tension pneumothorax
Right ventricular dysfunction Massive hemothorax
Pericardial compression (tamponade)  
Rhythm disturbance  

LVOT, left ventricular outflow tract.

Table 20-5 A Stepwise Approach to the Diagnosis and Initial Treatment of the Hemodynamically Unstable Postoperative Cardiac Patient

Step 1. Confirm the Presence of Hemodynamic Instability.
Check the level and zero all transducers. Relevel and rezero all pressure transducers if necessary.
Check all infusion pumps and the integrity of all infusion lines.
Step 2. Does the Patient Have an Immediately Life-threatening Problem (i.e., MAP < 50 mmHg)?
If so, go to Fig. 20-3.
Step 3. Clinically Assess the Patient (Steps 3 and 4 Should Occur Simultaneously).
Perform a targeted physical exam, concentrating on the cardiac and respiratory systems, the ventilator, and the chest drains.
Review the 24-hour chart.
Obtain relevant investigations: blood gases, SSVCO2, ECG (atrial and 12-lead), and chest radiograph.
Review the old notes and the intraoperative course.
Inform the surgeon.
Step 4. Consider the Following Interventions.
Paralyze and sedate the patient and ventilate with 100% oxygen. If indicated, disconnect the patient from the ventilator and hand ventilate with a manual resuscitator.
Pace the heart at 90 beats/min using DDD or DOO mode at maximum output (see Chapter 21).
Administer a fluid challenge of 500 ml of a crystalloid (e.g., normal saline or Plasma-Lyte).
Commence or increase inotropic support.
Step 5. If the Diagnosis Remains Uncertain, Insert a PAC and/or Perform an Echocardiogram.
If there is clinical suspicion of low or high cardiac output, a PAC should be inserted.
If a PAC is in place and cardiac output is low, an echocardiogram should be performed.
If the patient remains hypotensive and the cause is unclear, an echocardiogram should be performed.
If a specific diagnosis (e.g., tamponade) is suspected clinically, an echocardiogram should be performed.

ECG, electrocardiogram; MAP, mean arterial pressure; PAC, pulmonary artery catheter.

If the cause of hypotension or low cardiac output is not rapidly apparent, an echocardiogram should be performed. Pulmonary artery catheterization and echocardiography are complementary techniques: a PAC is preferred for measuring cardiac output, whereas an echocardiogram is preferred for diagnosing the cause of low cardiac output and hypotension. In the ICU, transesophageal echocardiography (TEE) offers significant advantages over transthoracic echocardiography (TTE) (see Chapter 7).


Hypovolemia is a reduction in circulating blood volume such that left ventricular preload is inadequate to optimize cardiac output (see Chapter 1). Preload is usually equated with left ventricular end-diastolic volume (LVEDV), but surrogates such as left ventricular end-diastolic area (LVEDA), PAWP, and CVP are also used.

In the general ICU environment, approximately 50% of hypotensive patients are fluid responsive.4 Hypovolemia is common following cardiac surgery, as a consequence of blood, urinary, and third-space fluid losses. Blood loss may be visible (seen in the chest drains) or occult (unseen in the chest, retroperitoneum, or gastrointestinal tract). Urinary losses may be substantial in the first few hours following surgery, particularly if hypothermic CPB has been employed or mannitol has been used in the circuit prime. Third-space losses are variable but may involve several liters. In one study, the average weight gain after cardiac surgery was 7.2% of body weight on the first postoperative day.5 Thus, hypovolemia can occur despite a substantial increase in total extracellular volume. In critically unwell patients, hypovolemia and systemic edema often coexist.


Hypovolemia is usually obvious on the basis of clinical signs and invasive hemodynamic monitoring. However, in certain situations the clinical picture is confusing. Young patients with intact cardiovascular reflexes can have important hypovolemia without showing clinical indicators, whereas modest hypovolemia can cause profound hypotension in elderly patients who are mechanically ventilated and have blunted sympathetic tone. Hypovolemia frequently coexists with other causes of hemodynamic instability, complicating the diagnosis. The surrogates of preload, CVP and pawp, are often misleading (see Chapters 1 and Chapter 8).

Hemodynamic Monitoring.

Hypovolemia is normally characterized by hypotension in association with low atrial pressures. A patient with a CVP below 8 mmHg or a PAWP below 10 mmHg, in the presence of hypotension, is invariably fluid responsive. However, there are no absolute values for CVP and PAWP that predict fluid responsiveness,6,7 and in many circumstances patients with much higher filling pressures also benefit from fluid administration. High CVP may be caused by right ventricular dysfunction or high intrathoracic or intrapericardial pressure. A CVP above 15 mmHg is occasionally required so as to optimize cardiac output in patients with right ventricular dysfunction.4,6 Conversely, in patients with left ventricular dysfunction, CVP may be low despite circulatory overload. In cases of severe left ventricular hypertrophy, PAWP may have to be above 18 mmHg to optimize preload.4 The causes of high CVP and PAWP are listed in Tables 8-3 and 8-4, respectively.

In contrast to absolute values of CVP and PAWP, respiratory fluctuations in CVP and the arterial pressure waveform (pulsus paradoxus) are predictive of fluid responsiveness (see Chapter 8).4 A patient with a respiratory swing on the arterial waveform is invariably fluid responsive, irrespective of the atrial pressure.

Low Systemic Vascular Resistance

Pathologic vasodilatation after cardiac surgery is most commonly a manifestation of severe inflammatory response to CPB and surgical stress (see Chapter 2). Other causes include vasodilator drug therapy, anaphylaxis, sepsis, and adrenal failure. Low systemic resistance occurs in 20% to 45% of patients after cardiac surgery,10,11 and severe vasodilatory shock occurs in 5% to 10%.11,12 Risk factors for pathologic vasodilatation include low ejection fraction, prolonged CPB, and prior treatment with ACE inhibitors.

Left Ventricular Systolic Dysfunction

Left ventricular systolic dysfunction may be acute, chronic, or a combination of both.


Chronic left ventricular systolic dysfunction results in remodeling (see Chapter 1), usually as a consequence of myocardial infarction, chronic ischemia (hibernating myocardium), or valvular heart disease. Ejection fraction is reduced and ventricular volumes are increased. A patient with compensated heart failure may have a normal cardiac output and left atrial pressure and, despite a low ejection fraction, may have good functional capacity. Such a patient often has an uneventful postoperative course. However, decompensation may occur if: (1) there is a further myocardial insult (e.g., myocardial stunning); (2) ventricular afterload is abruptly increased (e.g., after tracheal extubation or the withholding of usual vasodilator therapy); (3) there is a requirement for increased cardiac output (e.g., a severe inflammatory response to CPB).


Acute left ventricular systolic dysfunction occurs due to myocardial ischemia, acute infarction, myocardial stunning, drugs (e.g., β blockers), or systemic inflammation. Some degree of myocardial stunning occurs in all patients after cardiac surgery.14 However, severe postoperative stunning is likely when: (1) CPB is complicated or greatly prolonged; (2) severe myocardial ischemia was present preoperatively. With acute dysfunction, ejection fraction is reduced but ventricular volumes may be relatively normal. Cardiac output is reduced, left atrial pressure is increased, and there may be signs of pulmonary congestion and tissue hypoperfusion.

Myocardial ischemia must always be considered in any patient who develops new left ventricular systolic dysfunction. The patients at the highest risk for myocardial ischemia are those undergoing coronary revascularization (see Chapter 9), but ischemia can also occur in other situations, namely, the obstruction of a coronary ostium during aortic valve replacement; the kinking or obstruction of a coronary artery following its reimplantation during aortic root replacement; damage to the circumflex coronary artery during mitral valve surgery; and damage to the septal branch of the left anterior descending coronary artery as it runs in front of the pulmonary valve during the Ross procedure (see Chapter 10).



With chronic left ventricular systolic dysfunction, ventricular dimensions are increased, systolic wall movement and thickening are reduced, and ejection fraction is low. Because of the effects of remodeling, changes in wall motion are typically global (in addition to any segmental wall motion abnormalities secondary to ischemia and infarction).

With acute dysfunction, ventricular volumes may be relatively normal. Changes in wall motion are typically regional rather than global. The left atrium may appear tense and enlarged and may show rightward bowing of the interatrial septum. With tissue Doppler, the E deceleration time is likely to be short (<140 ms) and the E:Em ratio is likely to be high (<15; see Chapter 7).

When grading systolic function by echocardiography, the effects of loading conditions (e.g., systemic vascular resistance, mitral regurgitation) and inotropic support must be considered (see Difficult Diagnoses in subsequent material). If systolic dysfunction is identified on the echocardiogram, the following questions should be asked to help determine whether it is the primary cause of the observed hemodynamic instability:

The diagnosis of postoperative myocardial ischemia rests on clinical suspicion and characteristic abnormalities on the ECG, echocardiogram, and biochemical markers (see Chapters 9 and Chapter 18).


Preload, heart rate, and rhythm should be optimized. A heart rate of 80 to 100 beats per minute, using pacing if necessary, is appropriate for most patients. Inotropic support should then be commenced and titrated to effect. The choice of drug depends on the hemodynamic state. If cardiac output is low but blood pressure is satisfactory, an inodilator such as dobutamine or milrinone may be used. If both blood pressure and cardiac output are low, epinephrine or a combination of norepinephrine and milrinone (or dobutamine) may be used. If hemodynamic instability persists despite modest inotropic support (epinephrine 0.1 to 0.2 μ/kg/min or equivalent), insertion of an intraaortic balloon pump (IABP) should be considered (see Chapter 22). In patients with systolic ventricular dysfunction, high-dose norepinephrine can cause a precipitous fall in cardiac output and should be avoided unless cardiac output is being measured.

Combinations of inotropic drugs at high dosages (e.g., norepinephrine plus milrinone; or epinephrine/dopamine plus milrinone, and vasopressin) in conjunction with an IABP are sometimes required for severe postoperative myocardial stunning, and biventricular failure. If the hemodynamic state remains inadequate despite an IABP and combination high-dosage inotropic pharmacotherapy, and cardiac dysfunction is potentially reversible, placement of a ventricular assist device should be considered (see Chapter 22).

Buy Membership for Cardiothoracic Surgery Category to continue reading. Learn more here